HEADER TRANSFERASE 11-JUL-23 8PQ9 TITLE C-KIT KINASE DOMAIN IN COMPLEX WITH AVAPRITINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO-ONCOGENE C-KIT, COMPND 5 TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY-ZUCKERMAN 4 FELINE COMPND 6 SARCOMA VIRAL ONCOGENE HOMOLOG; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIT, SCFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS C-KIT PROTEIN KINASE, AVAPRITINIB, INHIBITOR, TYROSINE KINASE, KEYWDS 2 TRANSMEMBRANE RECEPTOR, STEM CELL FACTOR, SCF, STEM CELL FACTOR KEYWDS 3 RECEPTOR, GIST, GASTROINTESTINAL STROMAL TUMORS, P10721, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.TEUBER,S.KLEINBOELTING,M.P.MUELLER,D.RAUH REVDAT 3 13-MAR-24 8PQ9 1 REMARK REVDAT 2 17-JAN-24 8PQ9 1 JRNL REVDAT 1 27-DEC-23 8PQ9 0 JRNL AUTH A.TEUBER,T.SCHULZ,B.S.FLETCHER,R.GONTLA,T.MUHLENBERG, JRNL AUTH 2 M.L.ZISCHINSKY,J.NIGGENABER,J.WEISNER,S.B.KLEINBOLTING, JRNL AUTH 3 J.LATEGAHN,S.SIEVERS,M.P.MULLER,S.BAUER,D.RAUH JRNL TITL AVAPRITINIB-BASED SAR STUDIES UNVEIL A BINDING POCKET IN KIT JRNL TITL 2 AND PDGFRA. JRNL REF NAT COMMUN V. 15 63 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38167404 JRNL DOI 10.1038/S41467-023-44376-8 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 74920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3745 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.0000 - 5.1000 1.00 2865 151 0.1841 0.1638 REMARK 3 2 5.0900 - 4.0500 1.00 2748 144 0.1455 0.1507 REMARK 3 3 4.0500 - 3.5400 1.00 2682 142 0.1501 0.1610 REMARK 3 4 3.5400 - 3.2100 1.00 2685 141 0.1808 0.1930 REMARK 3 5 3.2100 - 2.9800 1.00 2648 139 0.1915 0.2051 REMARK 3 6 2.9800 - 2.8100 1.00 2670 141 0.1946 0.2314 REMARK 3 7 2.8100 - 2.6700 1.00 2671 140 0.1940 0.2041 REMARK 3 8 2.6700 - 2.5500 1.00 2621 138 0.2007 0.2069 REMARK 3 9 2.5500 - 2.4500 1.00 2621 138 0.2004 0.2408 REMARK 3 10 2.4500 - 2.3700 1.00 2631 139 0.1992 0.2223 REMARK 3 11 2.3700 - 2.2900 1.00 2650 139 0.1976 0.2522 REMARK 3 12 2.2900 - 2.2300 1.00 2646 140 0.2030 0.2868 REMARK 3 13 2.2300 - 2.1700 1.00 2622 138 0.1997 0.2184 REMARK 3 14 2.1700 - 2.1200 1.00 2601 137 0.1983 0.2220 REMARK 3 15 2.1200 - 2.0700 1.00 2622 138 0.2264 0.2326 REMARK 3 16 2.0700 - 2.0200 1.00 2620 138 0.2405 0.2549 REMARK 3 17 2.0200 - 1.9800 1.00 2594 136 0.2244 0.2812 REMARK 3 18 1.9800 - 1.9500 1.00 2598 137 0.2218 0.2678 REMARK 3 19 1.9500 - 1.9100 1.00 2585 135 0.2232 0.2850 REMARK 3 20 1.9100 - 1.8800 1.00 2658 140 0.2387 0.2700 REMARK 3 21 1.8800 - 1.8500 1.00 2549 134 0.2421 0.2729 REMARK 3 22 1.8500 - 1.8200 1.00 2625 139 0.2729 0.3030 REMARK 3 23 1.8200 - 1.7900 1.00 2566 135 0.3094 0.3462 REMARK 3 24 1.7900 - 1.7700 1.00 2649 139 0.3346 0.3417 REMARK 3 25 1.7700 - 1.7400 1.00 2539 133 0.4012 0.4221 REMARK 3 26 1.7400 - 1.7200 1.00 2649 140 0.4495 0.5291 REMARK 3 27 1.7200 - 1.7000 1.00 2560 134 0.5068 0.4994 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.271 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.959 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4883 REMARK 3 ANGLE : 0.873 6654 REMARK 3 CHIRALITY : 0.055 719 REMARK 3 PLANARITY : 0.006 915 REMARK 3 DIHEDRAL : 5.237 744 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -2.4337 -4.2161 23.5751 REMARK 3 T TENSOR REMARK 3 T11: 0.2476 T22: 0.2462 REMARK 3 T33: 0.2609 T12: 0.0404 REMARK 3 T13: -0.0342 T23: -0.0107 REMARK 3 L TENSOR REMARK 3 L11: 0.2567 L22: 0.1209 REMARK 3 L33: 0.8325 L12: 0.0995 REMARK 3 L13: -0.3528 L23: -0.1796 REMARK 3 S TENSOR REMARK 3 S11: 0.0229 S12: -0.0092 S13: 0.0214 REMARK 3 S21: 0.0187 S22: 0.0019 S23: 0.0150 REMARK 3 S31: -0.1155 S32: -0.1086 S33: -0.0216 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PQ9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE. REMARK 100 THE DEPOSITION ID IS D_1292130356. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-AUG-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9998 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74995 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 47.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.37 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.4200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 13.43 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6.6 MG/ML, 10% PEG8000, 20% ETHYLEN REMARK 280 GLYCOLE, 30 MM NAI, 30 MM NAF, 30 MM NABR, 100 MM BICINE, PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 285.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.51000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 95.88000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.65000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 95.88000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.51000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.65000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 548 REMARK 465 SER A 549 REMARK 465 MET A 550 REMARK 465 PRO A 551 REMARK 465 MET A 552 REMARK 465 TYR A 553 REMARK 465 GLU A 554 REMARK 465 VAL A 555 REMARK 465 GLN A 556 REMARK 465 TRP A 557 REMARK 465 LYS A 558 REMARK 465 VAL A 559 REMARK 465 VAL A 560 REMARK 465 GLU A 561 REMARK 465 GLU A 562 REMARK 465 SER A 563 REMARK 465 ASN A 564 REMARK 465 GLY A 565 REMARK 465 TYR A 752 REMARK 465 LYS A 753 REMARK 465 VAL A 754 REMARK 465 ALA A 755 REMARK 465 PRO A 756 REMARK 465 GLU A 757 REMARK 465 ASP A 758 REMARK 465 LEU A 759 REMARK 465 TYR A 760 REMARK 465 LYS A 761 REMARK 465 THR A 932 REMARK 465 ASN A 933 REMARK 465 HIS A 934 REMARK 465 GLY C 548 REMARK 465 SER C 549 REMARK 465 MET C 550 REMARK 465 PRO C 551 REMARK 465 MET C 552 REMARK 465 TYR C 553 REMARK 465 GLU C 554 REMARK 465 VAL C 555 REMARK 465 GLN C 556 REMARK 465 TRP C 557 REMARK 465 LYS C 558 REMARK 465 VAL C 559 REMARK 465 VAL C 560 REMARK 465 GLU C 561 REMARK 465 GLU C 562 REMARK 465 SER C 563 REMARK 465 ASN C 564 REMARK 465 VAL C 754 REMARK 465 ALA C 755 REMARK 465 PRO C 756 REMARK 465 GLU C 757 REMARK 465 ASP C 758 REMARK 465 LEU C 759 REMARK 465 TYR C 760 REMARK 465 LYS C 761 REMARK 465 THR C 932 REMARK 465 ASN C 933 REMARK 465 HIS C 934 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 566 CG OD1 ND2 REMARK 470 LYS A 593 CG CD CE NZ REMARK 470 HIS A 630 CG ND1 CD2 CE1 NE2 REMARK 470 THR A 632 OG1 CG2 REMARK 470 GLU A 633 CG CD OE1 OE2 REMARK 470 ARG A 634 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 646 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 687 CG OD1 OD2 REMARK 470 GLU A 688 CG CD OE1 OE2 REMARK 470 ASP A 762 CG OD1 OD2 REMARK 470 PHE A 763 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN A 819 CG OD1 ND2 REMARK 470 SER A 821 OG REMARK 470 LYS A 826 CG CD CE NZ REMARK 470 LYS A 918 CG CD CE NZ REMARK 470 LYS A 926 CG CD CE NZ REMARK 470 ILE A 928 CG1 CG2 CD1 REMARK 470 SER A 931 OG REMARK 470 ASN C 566 CG OD1 ND2 REMARK 470 LYS C 593 CG CD CE NZ REMARK 470 PHE C 600 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE C 612 CG1 CG2 CD1 REMARK 470 LYS C 613 CG CD CE NZ REMARK 470 SER C 614 OG REMARK 470 ASP C 615 CG OD1 OD2 REMARK 470 TYR C 646 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP C 687 CG OD1 OD2 REMARK 470 LYS C 693 CG CD CE NZ REMARK 470 ASP C 762 CG OD1 OD2 REMARK 470 PHE C 763 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C 818 CG CD CE NZ REMARK 470 LYS C 826 CG CD CE NZ REMARK 470 ASN C 828 CG OD1 ND2 REMARK 470 GLN C 922 CG CD OE1 NE2 REMARK 470 LYS C 926 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 792 48.59 -142.93 REMARK 500 ASP A 810 85.59 62.85 REMARK 500 ASP C 792 47.29 -143.39 REMARK 500 THR C 801 -165.29 -127.15 REMARK 500 ASP C 810 87.15 61.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1329 DISTANCE = 6.77 ANGSTROMS REMARK 525 HOH C1357 DISTANCE = 5.81 ANGSTROMS DBREF 8PQ9 A 551 687 UNP P10721 KIT_HUMAN 551 687 DBREF 8PQ9 A 766 934 UNP P10721 KIT_HUMAN 766 934 DBREF 8PQ9 C 551 687 UNP P10721 KIT_HUMAN 551 687 DBREF 8PQ9 C 766 934 UNP P10721 KIT_HUMAN 766 934 SEQADV 8PQ9 GLY A 548 UNP P10721 EXPRESSION TAG SEQADV 8PQ9 SER A 549 UNP P10721 EXPRESSION TAG SEQADV 8PQ9 MET A 550 UNP P10721 EXPRESSION TAG SEQADV 8PQ9 SER A 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 8PQ9 SER A 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 8PQ9 GLN A 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 8PQ9 SER A 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 8PQ9 GLU A 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 8PQ9 HIS A 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 8PQ9 GLU A 688 UNP P10721 LINKER SEQADV 8PQ9 PHE A 689 UNP P10721 LINKER SEQADV 8PQ9 VAL A 690 UNP P10721 LINKER SEQADV 8PQ9 PRO A 691 UNP P10721 LINKER SEQADV 8PQ9 TYR A 752 UNP P10721 LINKER SEQADV 8PQ9 LYS A 753 UNP P10721 LINKER SEQADV 8PQ9 VAL A 754 UNP P10721 LINKER SEQADV 8PQ9 ALA A 755 UNP P10721 LINKER SEQADV 8PQ9 PRO A 756 UNP P10721 LINKER SEQADV 8PQ9 GLU A 757 UNP P10721 LINKER SEQADV 8PQ9 ASP A 758 UNP P10721 LINKER SEQADV 8PQ9 LEU A 759 UNP P10721 LINKER SEQADV 8PQ9 TYR A 760 UNP P10721 LINKER SEQADV 8PQ9 LYS A 761 UNP P10721 LINKER SEQADV 8PQ9 ASP A 762 UNP P10721 LINKER SEQADV 8PQ9 PHE A 763 UNP P10721 LINKER SEQADV 8PQ9 LEU A 764 UNP P10721 LINKER SEQADV 8PQ9 THR A 765 UNP P10721 LINKER SEQADV 8PQ9 HIS A 768 UNP P10721 ASP 768 ENGINEERED MUTATION SEQADV 8PQ9 ASN A 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 8PQ9 ASP A 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 8PQ9 SER A 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 8PQ9 SER A 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 8PQ9 TYR A 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 8PQ9 ASP A 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 8PQ9 ASP A 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQADV 8PQ9 GLY C 548 UNP P10721 EXPRESSION TAG SEQADV 8PQ9 SER C 549 UNP P10721 EXPRESSION TAG SEQADV 8PQ9 MET C 550 UNP P10721 EXPRESSION TAG SEQADV 8PQ9 SER C 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 8PQ9 SER C 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 8PQ9 GLN C 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 8PQ9 SER C 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 8PQ9 GLU C 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 8PQ9 HIS C 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 8PQ9 GLU C 688 UNP P10721 LINKER SEQADV 8PQ9 PHE C 689 UNP P10721 LINKER SEQADV 8PQ9 VAL C 690 UNP P10721 LINKER SEQADV 8PQ9 PRO C 691 UNP P10721 LINKER SEQADV 8PQ9 TYR C 692 UNP P10721 LINKER SEQADV 8PQ9 LYS C 693 UNP P10721 LINKER SEQADV 8PQ9 VAL C 754 UNP P10721 LINKER SEQADV 8PQ9 ALA C 755 UNP P10721 LINKER SEQADV 8PQ9 PRO C 756 UNP P10721 LINKER SEQADV 8PQ9 GLU C 757 UNP P10721 LINKER SEQADV 8PQ9 ASP C 758 UNP P10721 LINKER SEQADV 8PQ9 LEU C 759 UNP P10721 LINKER SEQADV 8PQ9 TYR C 760 UNP P10721 LINKER SEQADV 8PQ9 LYS C 761 UNP P10721 LINKER SEQADV 8PQ9 ASP C 762 UNP P10721 LINKER SEQADV 8PQ9 PHE C 763 UNP P10721 LINKER SEQADV 8PQ9 LEU C 764 UNP P10721 LINKER SEQADV 8PQ9 THR C 765 UNP P10721 LINKER SEQADV 8PQ9 HIS C 768 UNP P10721 ASP 768 ENGINEERED MUTATION SEQADV 8PQ9 ASN C 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 8PQ9 ASP C 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 8PQ9 SER C 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 8PQ9 SER C 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 8PQ9 TYR C 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 8PQ9 ASP C 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 8PQ9 ASP C 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQRES 1 A 327 GLY SER MET PRO MET TYR GLU VAL GLN TRP LYS VAL VAL SEQRES 2 A 327 GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP PRO SEQRES 3 A 327 THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO ARG SEQRES 4 A 327 ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY ALA SEQRES 5 A 327 PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU ILE SEQRES 6 A 327 LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET LEU SEQRES 7 A 327 LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU MET SEQRES 8 A 327 SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS GLU SEQRES 9 A 327 ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY GLY SEQRES 10 A 327 PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY ASP SEQRES 11 A 327 LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE VAL SEQRES 12 A 327 PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP PHE SEQRES 13 A 327 LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN VAL SEQRES 14 A 327 ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE SEQRES 15 A 327 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR HIS SEQRES 16 A 327 GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 17 A 327 ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY ASN SEQRES 18 A 327 ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE SEQRES 19 A 327 PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SER SEQRES 20 A 327 TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SER SEQRES 21 A 327 SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE TYR SEQRES 22 A 327 LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO GLU SEQRES 23 A 327 TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR CYS SEQRES 24 A 327 TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS GLN SEQRES 25 A 327 ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER THR SEQRES 26 A 327 ASN HIS SEQRES 1 C 327 GLY SER MET PRO MET TYR GLU VAL GLN TRP LYS VAL VAL SEQRES 2 C 327 GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP PRO SEQRES 3 C 327 THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO ARG SEQRES 4 C 327 ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY ALA SEQRES 5 C 327 PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU ILE SEQRES 6 C 327 LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET LEU SEQRES 7 C 327 LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU MET SEQRES 8 C 327 SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS GLU SEQRES 9 C 327 ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY GLY SEQRES 10 C 327 PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY ASP SEQRES 11 C 327 LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE VAL SEQRES 12 C 327 PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP PHE SEQRES 13 C 327 LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN VAL SEQRES 14 C 327 ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE SEQRES 15 C 327 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR HIS SEQRES 16 C 327 GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 17 C 327 ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY ASN SEQRES 18 C 327 ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE SEQRES 19 C 327 PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SER SEQRES 20 C 327 TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SER SEQRES 21 C 327 SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE TYR SEQRES 22 C 327 LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO GLU SEQRES 23 C 327 TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR CYS SEQRES 24 C 327 TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS GLN SEQRES 25 C 327 ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER THR SEQRES 26 C 327 ASN HIS HET 9JI A1001 37 HET 9JI C1001 37 HET SO4 C1002 5 HETNAM 9JI (1~{S})-1-(4-FLUOROPHENYL)-1-[2-[4-[6-(1-METHYLPYRAZOL- HETNAM 2 9JI 4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL]PIPERAZIN-1- HETNAM 3 9JI YL]PYRIMIDIN-5-YL]ETHANAMINE HETNAM SO4 SULFATE ION FORMUL 3 9JI 2(C26 H27 F N10) FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *486(H2 O) HELIX 1 AA1 ASP A 572 LEU A 576 5 5 HELIX 2 AA2 ASP A 579 GLU A 583 5 5 HELIX 3 AA3 PRO A 585 ASN A 587 5 3 HELIX 4 AA4 HIS A 630 GLY A 648 1 19 HELIX 5 AA5 LEU A 678 ARG A 686 1 9 HELIX 6 AA6 THR A 765 LYS A 786 1 22 HELIX 7 AA7 ALA A 794 ARG A 796 5 3 HELIX 8 AA8 HIS A 802 ASN A 804 5 3 HELIX 9 AA9 PRO A 832 MET A 836 5 5 HELIX 10 AB1 ALA A 837 SER A 844 1 8 HELIX 11 AB2 THR A 847 SER A 864 1 18 HELIX 12 AB3 ASP A 876 GLY A 886 1 11 HELIX 13 AB4 PRO A 896 TRP A 907 1 12 HELIX 14 AB5 ASP A 910 ARG A 914 5 5 HELIX 15 AB6 THR A 916 GLU A 930 1 15 HELIX 16 AB7 ASP C 572 LEU C 576 5 5 HELIX 17 AB8 ASP C 579 GLU C 583 5 5 HELIX 18 AB9 PRO C 585 ASN C 587 5 3 HELIX 19 AC1 HIS C 630 GLY C 648 1 19 HELIX 20 AC2 LEU C 678 ARG C 686 1 9 HELIX 21 AC3 ASP C 687 PHE C 689 5 3 HELIX 22 AC4 THR C 765 LYS C 786 1 22 HELIX 23 AC5 ALA C 794 ARG C 796 5 3 HELIX 24 AC6 HIS C 802 ASN C 804 5 3 HELIX 25 AC7 PRO C 832 MET C 836 5 5 HELIX 26 AC8 ALA C 837 SER C 844 1 8 HELIX 27 AC9 THR C 847 SER C 864 1 18 HELIX 28 AD1 ASP C 876 GLY C 886 1 11 HELIX 29 AD2 PRO C 896 TRP C 907 1 12 HELIX 30 AD3 ASP C 910 ARG C 914 5 5 HELIX 31 AD4 THR C 916 SER C 931 1 16 SHEET 1 AA1 5 LEU A 589 ALA A 597 0 SHEET 2 AA1 5 GLY A 601 GLN A 609 -1 O GLU A 605 N GLY A 592 SHEET 3 AA1 5 ALA A 617 LEU A 625 -1 O MET A 618 N ALA A 608 SHEET 4 AA1 5 LEU A 667 GLU A 671 -1 O VAL A 668 N LYS A 623 SHEET 5 AA1 5 LEU A 656 CYS A 660 -1 N LEU A 657 O ILE A 669 SHEET 1 AA2 3 GLY A 676 ASP A 677 0 SHEET 2 AA2 3 ILE A 798 THR A 801 -1 O LEU A 800 N GLY A 676 SHEET 3 AA2 3 ILE A 805 ILE A 808 -1 O LYS A 807 N LEU A 799 SHEET 1 AA3 2 CYS A 788 ILE A 789 0 SHEET 2 AA3 2 ARG A 815 ASP A 816 -1 O ARG A 815 N ILE A 789 SHEET 1 AA4 2 TYR A 823 VAL A 824 0 SHEET 2 AA4 2 VAL A 845 TYR A 846 -1 O TYR A 846 N TYR A 823 SHEET 1 AA5 5 LEU C 589 ALA C 597 0 SHEET 2 AA5 5 GLY C 601 GLN C 609 -1 O GLU C 605 N GLY C 592 SHEET 3 AA5 5 ALA C 617 LEU C 625 -1 O MET C 624 N LYS C 602 SHEET 4 AA5 5 LEU C 667 GLU C 671 -1 O VAL C 668 N LYS C 623 SHEET 5 AA5 5 LEU C 656 CYS C 660 -1 N LEU C 657 O ILE C 669 SHEET 1 AA6 3 GLY C 676 ASP C 677 0 SHEET 2 AA6 3 ILE C 798 THR C 801 -1 O LEU C 800 N GLY C 676 SHEET 3 AA6 3 ILE C 805 ILE C 808 -1 O LYS C 807 N LEU C 799 SHEET 1 AA7 2 CYS C 788 ILE C 789 0 SHEET 2 AA7 2 ARG C 815 ASP C 816 -1 O ARG C 815 N ILE C 789 SHEET 1 AA8 2 TYR C 823 VAL C 824 0 SHEET 2 AA8 2 VAL C 845 TYR C 846 -1 O TYR C 846 N TYR C 823 CRYST1 59.020 59.300 191.760 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016943 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016863 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005215 0.00000